PHARMAGEN, INC. Additional Paid in Capital
PHARMAGEN, INC. had Additional Paid in Capital of $1.32 million as of 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2014-05-15
- 2014-03-31: Additional Paid in Capital $1.32M.
- 2013-12-31: Additional Paid in Capital $1.48M.
- 2013-09-30: Additional Paid in Capital $940.61K.
- 2013-06-30: Additional Paid in Capital $461.45K.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2014-03-31 | $1.32M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.48M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $940.61K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $461.45K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $417.70K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $165.94K 10-K · filed 2014-03-31 | |
| 2012-09-30 | -$268.75K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$270.94K 10-Q/A · filed 2012-09-14 | |
| 2012-03-31 | -$364.00K 10-Q · filed 2012-06-11 | |
| 2011-12-31 | -$196.13K 10-K · filed 2013-04-01 | -$330.56K 10-Q · filed 2012-02-13 |
| 2011-09-30 | $31.71K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$330.56K 10-Q · filed 2012-02-13 | $31.71K 10-Q · filed 2011-11-14 |